tracpnuzvyqbgdleokims

NEUROMUSCULAR BLOCKING DRUGS

Patient who have received n.m.b.drug should always have

their respiration assisted, or controlled until drug has been
inactivated , n should receive concomitant inhalational / iv
anaesthetics / sedatives to prevent awareness

NEUROMUSCULAR BLOCKING DRUGS

tdnfohrreu sgine t ucw baitnahtbiosehn ofau nr tdh emdruecclahts vo einfineltidkileaa-tsiot-nrsah,coau r tdiur mu g is c h o s e n a c o r d in g t o n s e t o f e ff e c t , d u r a t io n o f a c t io n s id e ff e c t s

a,oavctertaincu gr o(n1 i5u -m3n0 amc riesn ttmas c)our eiuwm id me lay u bs e ds u it a b le fo r lo n g t e r m n e u r o m u s c u la r b lo a c k a d e s in c e d u r a t io n o f a c t io n is n o t
nd e p e n d e n t o n e lim in a t io n e it h e r b y liv e r o r k id n e y
r o c u r o n iu m h a s r a p id o n s e t o f a c t io n a n d it s u it a b le f o r in t u b a t io n

NEUROMUSCULAR BLOCKING DRUGS

s
re
c
d
n
tio
a
b
h
w
u
q
y
,p
m
l
v

a
p
w
lo
h
c
m
s
e
n
ity
rv
u
fd
q

ocurnim:expadv-stqlbzfwh2g,10y
NEUROMUSCULAR BLOCKING DRUGS

NEUROMUSCULAR BLOCKING DRUGS

Atracuriu
m
besylate

Neuromus
cular
blockade
(short to
intermedia
te) for
surgery ,
or during
intensive
care

Caution:pre
gnancy n
breast
feeding
Does not
cross
placental
barrier but
mfg
advises to
use only if
benefit
outweighs
adverse
effect
-avoid
breast
feeding for
24 hrs after
administrat
ion

Adult n child
dose:iv inj300-600
microgram
/kg then 100200
microgram/kg
or as required
Iv inj 200-600
microgram/kg
followed by iv
infusion , 510
microgram/kg
/Minute(300600
microgram/kg
/hr)

Store at 2-8 c
, at 5c
approximatel
y6%
potency is
lossed /per
At 22c rate of
potency loss
is 5 %/month
Upon removal
from
refrigerator
use with in 14
days , even if
re
refrigerated